FDA approves GLP-1 generic for Type 2 diabetes
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
Managed Healthcare Executive19h
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
southernillinoisnow19h
IDPH Announces that Illinois Respiratory Surveillance Data Show Uptick in Seasonal Illnesses
The Illinois Department of Public Health (IDPH) announced that the state’s overall respiratory illness level has moved up from Low to Moderate.  That means that Illinoisans face an increased chance of ...